Tag: Liver Disease: Misc.
More Than Four in 10 U.S. Adults Have Fatty Liver Disease
Higher risk seen among men, those 40 years and older, those with higher body mass index, and people with other comorbidities
Low Zinc Levels Seen With Liver Cirrhosis, Hepatic Encephalopathy
Zinc deficiency is significantly associated with higher severity of cirrhosis and higher grades of hepatic encephalopathy
Small but Important Differences Seen Between Rosuvastatin, Atorvastatin
Rosuvastatin tied to cardiovascular and mortality benefits but also higher risk for type 2 diabetes
ACG: Fewer Overt Hepatic Encephalopathy Episodes Seen With Rifaximin
Rifaximin monotherapy reduces risk for breakthrough OHE episode and results in a lower mortality rate than lactulose monotherapy
Automated Speech Analysis Correlates With Hepatic Encephalopathy Tests
Automated speech analysis also associated with minimal HE and can predict future overt HE
Referral to Hepatology Low With Excessive Alcohol Use, High FIB-4
Referral lower for patients with mental health admissions or mental health diagnoses and with increasing age
GLP-1 RA Use Linked to Reduced Cirrhosis Risk in MASLD, Diabetes
Compared with DPP-4i use, GLP-1 RA use also associated with lower risk for composite of cirrhosis complications, mortality
Liver Grafts Feasible From Hep C-Positive Donors After Circulatory Death
One-year patient and graft survival comparable to donation after brain death, with or without HCV infection
People With Chronic Liver Disease Face More Barriers to Health Care
Findings tied to higher prevalence of socioeconomic vulnerabilities compared with those with chronic obstructive pulmonary disease or cardiovascular disease
New Definition of Steatotic Liver Disease Improves Prediction of Kidney Disease
Classification of SLD based on the presence of metabolic dysfunction and alcohol consumption
